...
首页> 外文期刊>Journal of Clinical Movement Disorders >Reversible craniocervical dystonia associated with levofloxacin
【24h】

Reversible craniocervical dystonia associated with levofloxacin

机译:与左氧氟沙星相关的可逆性颅颈肌张力障碍

获取原文
           

摘要

BackgroundDystonia is a hyperkinetic movement disorder related to dysfunction of inhibitory basal ganglia and cortical circuits. GABA is the major inhibitory neurotransmitter in the central nervous system. Quinolones can rarely produce serious neurologic effects, which have been attributed to impaired inhibition through GABA antagonism. We report a case of reversible craniocervical dystonia associated with oral levofloxacin. Case presentationA 62-year-old man on hemodialysis presented with craniocervical dystonia 3?days after initiation of levofloxacin 500?mg. twice daily. Levofloxacin was discontinued. Seven days later the abnormal movements completely disappeared and did not recur in the following 3?months. ConclusionLevofloxacin should be considered as a rare but potentially reversible trigger of craniocervical dystonia. Older age, renal impairment and high doses of the drug might be risk factors.
机译:背景肌张力障碍是一种运动过度性运动障碍,与抑制性基底节和皮质回路功能障碍有关。 GABA是中枢神经系统中主要的抑制性神经递质。喹诺酮类药物很少会产生严重的神经系统作用,这归因于通过GABA拮抗作用而抑制作用减弱。我们报告了一例与口服左氧氟沙星相关的可逆性颅颈肌张力障碍。病例介绍一名接受血液透析的62岁男子在500毫克左氧氟沙星起始后3天出现颅颈肌张力障碍。每天两次。左氧氟沙星停用。七天后,异常运动完全消失,在接下来的3个月中没有再出现。结论左氧氟沙星应被认为是一种罕见的但可能可逆的颅脑肌张力障碍的诱因。高龄,肾功能不全和高剂量药物可能是危险因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号